Literature DB >> 11555641

Foxl1 controls the Wnt/beta-catenin pathway by modulating the expression of proteoglycans in the gut.

N Perreault1, J P Katz, S D Sackett, K H Kaestner.   

Abstract

Foxl1 is a winged helix transcription factor expressed in the mesenchyme of the gastrointestinal tract. Foxl1 null mice display severe structural defects in the epithelia of the stomach, duodenum, and jejunum. Here we addressed the molecular mechanisms by which Foxl1 controls gastrointestinal differentiation. First we showed that the abnormalities found in the epithelia of the null mice are the result of an increase in the number of proliferating cells and not a change in the rate of cell migration. Next we investigated the regulatory circuits affected by Foxl1. We focused on the Wnt/beta-catenin signaling pathway as a possible target of Foxl1 as it has been shown to play a central role in gastrointestinal proliferation. We demonstrated that Foxl1 activates the Wnt/beta-catenin pathway by increasing extracellular proteoglycans, which act as co-receptors for Wnt. Thus we establish that Foxl1 is involved in the regulation of the Wnt/beta-catenin pathway, providing a novel link in mesenchymal/epithelial cross-talk in the gut. Moreover, we provide the first example implicating proteoglycans in the regulation of cellular proliferation in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555641     DOI: 10.1074/jbc.M104366200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Transcriptional repressor foxl1 regulates central nervous system development by suppressing shh expression in zebra fish.

Authors:  Chisako Nakada; Shinya Satoh; Yoko Tabata; Ken-ichi Arai; Sumiko Watanabe
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

2.  Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury.

Authors:  Sarah L Pull; Jason M Doherty; Jason C Mills; Jeffrey I Gordon; Thaddeus S Stappenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

Review 3.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

4.  FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.

Authors:  Geng Zhang; Peijun He; Jochen Gaedcke; B Michael Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  Cancer Res       Date:  2013-06-25       Impact factor: 12.701

5.  Identification of novel mutations by exome sequencing in African American colorectal cancer patients.

Authors:  Hassan Ashktorab; Mohammad Daremipouran; Joe Devaney; Sudhir Varma; Hamed Rahi; Edward Lee; Babak Shokrani; Russell Schwartz; Michael L Nickerson; Hassan Brim
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

6.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

7.  Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon.

Authors:  Nathalie Perreault; Sara D Sackett; Jonathan P Katz; Emma E Furth; Klaus H Kaestner
Journal:  Genes Dev       Date:  2005-01-13       Impact factor: 11.361

Review 8.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

9.  FoxF1 and FoxL1 link hedgehog signaling and the control of epithelial proliferation in the developing stomach and intestine.

Authors:  Blair B Madison; Lindsay B McKenna; Diane Dolson; Douglas J Epstein; Klaus H Kaestner
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

10.  Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.

Authors:  Feng-Qiang Yang; Feng-Ping Yang; Wei Li; Min Liu; Guang-Chun Wang; Jian-Ping Che; Jian-Hua Huang; Jun-Hua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.